Primary Genes Promoting Cementoblast Differentiaton
促进成牙骨质细胞分化的初级基因
基本信息
- 批准号:7235626
- 负责人:
- 金额:$ 34.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAntisense OligonucleotidesBiologyBone remodelingCalciumCalcium SignalingCell LineCell physiologyCellsCementoblastCementum FormationComplementary DNAConditionCyclic AMP-Dependent Protein KinasesDental CementumDentistryDepthDinoprostDinoprostoneDominant-Negative MutationFiberFibroblastsGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGrowth FactorHormonesHumanIn VitroInterleukin-1MAP Kinase GeneMediatingMediator of activation proteinMessenger RNAMitogen-Activated Protein KinasesModelingMolecularMolecular BiologyMusNatural regenerationOsteoblastsOsteocalcinPGF receptorPathway interactionsPatternPeriodontal LigamentPeriodontiumPhenotypePlant RootsPolymerase Chain ReactionProstaglandin ReceptorProstaglandinsProstaglandins EProtein KinaseProtein OverexpressionProteinsRattusRegulationResearchRoleSignal TransductionStimulusStructureSurfaceTestingTranscription factor genesalveolar bonebasebone sialoproteincDNA Subtractionfluprostenolin vivoinhibitor/antagonistmRNA Expressionmineralizationosteopontinprogramsreceptorreceptor bindingresponserestorationsubtraction hybridizationtooltranscription factorwound
项目摘要
DESCRIPTION (provided by applicant): Periodontal regeneration is an important, yet unattainable, treatment objective in dentistry. Developing better regenerative treatments requires a deeper understanding of cementoblast, osteoblast, and PDL fibroblast biology. The recently established OC-CM cementoblastic cell line provides an invaluable research tool for studying cementoblast molecular biology. We found that prostaglandin (PG) E2 and fluprostenol (flup; a specific FP receptor agonist) promoted, while interleukin-1 (IL-1) inhibited, OC-CM mineralization and differentiation. These effects were reproducible in primary human cementoblasts. Mechanistically, receptor bound flup and IL-1 induce primary genes, which regulate downstream genes and ultimately control cell function. Some primary genes are induced by both flup and IL-I, while others are preferentially induced by each treatment. We hypothesize that preferentially induced primary genes dictate flup- and IL-l-regulated cementoblast function. To identify primary genes we performed subtraction hybridization using OC-CM cells treated with 0.1 (M flup or 10 ng/ml IL-1 for 90 min. Two cDNA subtractions were performed: (a) flup - IL-l, to identify flup-induced genes and (b) IL-1 - flup, to identify IL-l-induced genes. Several preferentially induced primary genes were identified. Our objective is to study the role of the transcription factors Nur77 and egr1, and the MAP kinase signaling regulator mkp1 in cementoblast function. In preliminary studies, mRNA from all three genes was rapidly and transiently induced by flup, but not by IL-1, in OC-CM cells. This temporal pattern of Nur77, egr1, and mkp1 mRNA expression was replicated in primary human cementoblasts and primary mouse osteoblasts treated with flup. We propose three Specific Aims: 1) to characterize Nur77, egr1, and mkp1 gene regulation by prostanoids in cementoblasts, 2) to characterize Nur77, egr1, and mkp1 protein involvement in regulating cementoblast gene expression and differentiation, and 3) to examine PGE2 and PGF2alpha induction of Nur77, egr1, and mkp1 gene expression in cementoblasts in vivo. We anticipate that Nur77, egr1, and mkp1 will be key mediators of cementoblast differentiation. These studies will contribute to our understanding of the molecular signals that regulate cementoblast function.
描述(由申请人提供):牙周再生是牙科领域一个重要但难以实现的治疗目标。开发更好的再生治疗需要更深入地了解成牙骨质细胞,成骨细胞和PDL成纤维细胞生物学。最近建立的OC-CM成牙骨质细胞系为研究成牙骨质细胞分子生物学提供了一个宝贵的研究工具。我们发现,前列腺素(PG)E2和氟前列醇(flup;一种特异性FP受体激动剂)促进,而白细胞介素-1(IL-1)抑制,OC-CM矿化和分化。这些效应在原代人成牙骨质细胞中可重现。在机制上,受体结合的flup和IL-1诱导初级基因,其调节下游基因并最终控制细胞功能。一些主要基因被flup和IL-1诱导,而其他基因被每种处理优先诱导。我们假设优先诱导的初级基因决定flup和IL-1调节的成牙骨质细胞功能。为了鉴定初级基因,我们使用用0.1 μ M flup或10 ng/ml IL-1处理90分钟的OC-CM细胞进行消减杂交。进行两次cDNA消减:(a)flup-IL-1,以鉴定flup诱导的基因,和(B)IL-1-flup,以鉴定IL-1诱导的基因。几个优先诱导的主要基因进行了鉴定。我们的目的是研究转录因子Nur77和egr 1以及MAP激酶信号调节因子mkp 1在成牙骨质细胞功能中的作用。在初步研究中,来自所有三个基因的mRNA在OC-CM细胞中被flup快速和瞬时诱导,但不被IL-1诱导。Nur77,egr 1和mkp 1 mRNA表达的时间模式在用flup处理的原代人成牙骨质细胞和原代小鼠成骨细胞中复制。我们提出了三个具体目标:1)表征成牙骨质细胞中前列腺素类对Nur77、egr 1和mkp 1基因的调控,2)表征Nur77、egr 1和mkp 1蛋白参与调控成牙骨质细胞基因表达和分化,3)研究体内PGE2和PGF2 α对成牙骨质细胞中Nur77、egr 1和mkp 1基因表达的诱导作用。我们预期Nur77、egr 1和mkp 1将是成牙骨质细胞分化的关键介质。这些研究将有助于我们了解调节成牙骨质细胞功能的分子信号。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Prostaglandins E(2) and F(2alpha) enhance differentiation of cementoblastic cells.
前列腺素 E(2) 和 F(2α) 增强成牙骨质细胞的分化。
- DOI:10.1902/jop.2005.76.2.303
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Camargo,PM;Lagos,R;Pirih,FQM;Benitez,A;Nervina,JM;Tetradis,S
- 通讯作者:Tetradis,S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SOTIRIOS TETRADIS其他文献
SOTIRIOS TETRADIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SOTIRIOS TETRADIS', 18)}}的其他基金
Pathophysiologic Mechanisms of Bisphosphonate Related Osteonecrosis of the Jaws
双膦酸盐相关颌骨骨坏死的病理生理机制
- 批准号:
8893945 - 财政年份:2009
- 资助金额:
$ 34.34万 - 项目类别:
Pathophysiologic mechanisms during initiation of medication related osteonecrosis of the jaws
药物相关颌骨骨坏死起始过程中的病理生理机制
- 批准号:
10466925 - 财政年份:2009
- 资助金额:
$ 34.34万 - 项目类别:
Pathophysiologic Mechanisms of Bisphosphonate Related Osteonecrosis of the Jaws
双膦酸盐相关颌骨骨坏死的病理生理机制
- 批准号:
9115565 - 财政年份:2009
- 资助金额:
$ 34.34万 - 项目类别:
Pathophysiologic mechanisms during initiation of medication related osteonecrosis of the jaws
药物相关颌骨骨坏死起始过程中的病理生理机制
- 批准号:
10264918 - 财政年份:2009
- 资助金额:
$ 34.34万 - 项目类别:
Pathophysiologic Mechanisms of Bisphosphonate Related Osteonecrosis of the Jaws
双膦酸盐相关颌骨骨坏死的病理生理机制
- 批准号:
8761983 - 财政年份:2009
- 资助金额:
$ 34.34万 - 项目类别:
Pathophysiologic mechanisms during initiation of medication related osteonecrosis of the jaws
药物相关颌骨骨坏死起始过程中的病理生理机制
- 批准号:
10119690 - 财政年份:2009
- 资助金额:
$ 34.34万 - 项目类别:
Pathophysiologic mechanisms during initiation of medication related osteonecrosis of the jaws
药物相关颌骨骨坏死起始过程中的病理生理机制
- 批准号:
10686877 - 财政年份:2009
- 资助金额:
$ 34.34万 - 项目类别:
Primary Genes Promoting Cementoblast Differentiaton
促进成牙骨质细胞分化的初级基因
- 批准号:
6936009 - 财政年份:2003
- 资助金额:
$ 34.34万 - 项目类别:
Primary Genes Promoting Cementoblast Differentiaton
促进成牙骨质细胞分化的初级基因
- 批准号:
6598577 - 财政年份:2003
- 资助金额:
$ 34.34万 - 项目类别:
Primary Genes Promoting Cementoblast Differentiaton
促进成牙骨质细胞分化的初级基因
- 批准号:
6747942 - 财政年份:2003
- 资助金额:
$ 34.34万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 34.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 34.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 34.34万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 34.34万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 34.34万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 34.34万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 34.34万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 34.34万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 34.34万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 34.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)